Page last updated: 2024-11-03

procarbazine and Cancer of Pancreas

procarbazine has been researched along with Cancer of Pancreas in 2 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raymond, E1
Faivre, S1
Hammel, P1
Ruszniewski, P1
Hartman, HA1
Kessinger, A1
Lemon, HM1
Foley, JF1

Other Studies

2 other studies available for procarbazine and Cancer of Pancreas

ArticleYear
Sunitinib paves the way for targeted therapies in neuroendocrine tumors.
    Targeted oncology, 2009, Volume: 4, Issue:4

    Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoi

2009
Five-day continuous infusion of 5-fluorouracil for advanced colorectal, gastric, and pancreatic adenocarcinoma.
    Journal of surgical oncology, 1979, Volume: 11, Issue:3

    Topics: Adenocarcinoma; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Infus

1979